Kura Oncology, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
COGT
Cogent Biosciences, Inc. |
$8.19 | $802.20 M | -3.37 | 164 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$38.67 | $3.53 B | -11.86 | 290 | $4.01 M |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.40 | $1.12 B | -5.11 | 174 | $0 |
DSGN
Design Therapeutics, Inc. |
$5.18 | $217.51 M | -3.7 | 54 | $0 |
ERAS
Erasca, Inc. |
$1.93 | $647.94 M | -2.83 | 126 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.54 | $243.38 M | -1.59 | 133 | $0 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
INZY
Inozyme Pharma, Inc. |
$1.30 | $286.39 M | -3.43 | 59 | $0 |
KALV
KalVista Pharmaceuticals, Inc. |
$8.57 | $492.76 M | -3.74 | 150 | $0 |
KNSA
Kiniksa Pharmaceuticals, Ltd. |
$19.21 | $1.35 B | 146.62 | 297 | $270.26 M |
LRMR
Larimar Therapeutics, Inc. |
$3.46 | $611.84 M | -9.99 | 42 | $0 |
MRUS
Merus N.V. |
$40.58 | $3.50 B | -19.38 | 172 | $43.95 M |
PTGX
Protagonist Therapeutics, Inc. |
$36.86 | $2.04 B | 13.7 | 126 | $60.00 M |
REPL
Replimune Group, Inc. |
$13.01 | $485.18 M | -2.44 | 331 | $0 |
SNDX
Syndax Pharmaceuticals, Inc. |
$14.00 | $1.66 B | -6.02 | 184 | $0 |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
VRDN
Viridian Therapeutics, Inc. |
$18.37 | $776.72 M | -2.71 | 94 | $314,000 |
ZNTL
Zentalis Pharmaceuticals, Inc. |
$2.25 | $754.16 M | -3.26 | 124 | $0 |